# Zevra Therapeutics, Inc.: filings

ZVRA · Nasdaq · CIK 1434647 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zvra.md) · [Financials](/companies/zvra/financials.md) · [Filings](/companies/zvra/filings.md) · [Insiders](/companies/zvra/insiders.md)

## Reports and events: 274 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 284, 8-K 203, 10-Q 35, DEFA14A 34, 3 30, SC 13G/A 29, 424B3 24, CORRESP 20, 424B5 18, 144 17, UPLOAD 17, S-8 14, SC 13G 14, EFFECT 12, 10-K 11, D 10, DEF 14A 10, S-3 8, SCHEDULE 13G/A 7, 8-K/A 5, S-1/A 5, DEFC14A 4, CT ORDER 3, PREC14A 3, PRRN14A 3, S-1 3, SCHEDULE 13G 3, 424B4 2, 425 2, 8-A12B 2, D/A 2, DFAN14A 2, DRS/A 2, DRSLTR 2, POS AM 2, POS EX 2, PRE 14A 2, PRER14A 2, S-3/A 2, SEC STAFF LETTER 2, 10-K/A 1, 25-NSE 1, 424B2 1, CERT 1, CERTNAS 1, DRS 1, NT 10-Q 1, PREN14A 1, RW 1, S-1MEF 1, S-4 1, S-4/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 21:19 ET | [10-Q](/filings/0001434647-26-000068.md) | Quarterly report, period 2026-06-30 | 0001434647-26-000068 |
| 2026-08-05 | 20:13 ET | [8-K](/filings/0001434647-26-000067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001434647-26-000067 |
| 2026-06-05 | 20:19 ET | [8-K](/filings/0001434647-26-000041.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001434647-26-000041 |
| 2026-05-06 | 21:14 ET | [10-Q](/filings/0001434647-26-000031.md) | Quarterly report, period 2026-03-31 | 0001434647-26-000031 |
| 2026-05-06 | 20:05 ET | [8-K](/filings/0001434647-26-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001434647-26-000029 |
| 2026-04-20 | 13:00 ET | [DEF 14A](/filings/0001434647-26-000025.md) | Proxy statement, period 2026-06-04 | 0001434647-26-000025 |
| 2026-03-16 | 11:31 ET | [8-K](/filings/0001434647-26-000015.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001434647-26-000015 |
| 2026-03-09 | 20:23 ET | [10-K](/filings/0001434647-26-000011.md) | Annual report, period 2025-12-31 | 0001434647-26-000011 |
| 2026-03-09 | 20:06 ET | [8-K](/filings/0001434647-26-000009.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001434647-26-000009 |
| 2025-12-17 | 21:15 ET | [8-K](/filings/0001434647-25-000018.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001434647-25-000018 |
| 2025-12-02 | 12:34 ET | [8-K](/filings/0001434647-25-000015.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001434647-25-000015 |
| 2025-11-20 | 21:29 ET | [8-K](/filings/0001193125-25-289865.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-289865 |
| 2025-11-05 | 22:21 ET | [10-Q](/filings/0001434647-25-000011.md) | Quarterly report, period 2025-09-30 | 0001434647-25-000011 |
| 2025-11-05 | 21:08 ET | [8-K](/filings/0001434647-25-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001434647-25-000009 |
| 2025-08-12 | 21:24 ET | [10-Q](/filings/0001628280-25-039967.md) | Quarterly report, period 2025-06-30 | 0001628280-25-039967 |
| 2025-08-12 | 20:10 ET | [8-K](/filings/0001628280-25-039883.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-039883 |
| 2025-05-29 | 20:42 ET | [8-K](/filings/0001193125-25-130714.md) | 5.07 Shareholder vote results | 0001193125-25-130714 |
| 2025-05-13 | 21:15 ET | [10-Q](/filings/0001437749-25-016523.md) | Quarterly report, period 2025-03-31 | 0001437749-25-016523 |
| 2025-05-13 | 20:10 ET | [8-K](/filings/0001437749-25-016452.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016452 |
| 2025-04-07 | 12:04 ET | [8-K](/filings/0001193125-25-073991.md) | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-073991 |
| 2025-03-12 | 21:23 ET | [10-K](/filings/0001437749-25-007320.md) | Annual report, period 2024-12-31 | 0001437749-25-007320 |
| 2025-03-11 | 20:13 ET | [8-K](/filings/0001437749-25-007032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-007032 |
| 2025-02-27 | 12:38 ET | [8-K](/filings/0001193125-25-037619.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-037619 |
| 2024-12-06 | 22:28 ET | [8-K](/filings/0001437749-24-036876.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-036876 |
| 2024-11-22 | 23:39 ET | [8-K](/filings/0001437749-24-035988.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-035988 |
| 2024-11-13 | 21:18 ET | [10-Q](/filings/0001437749-24-034916.md) | Quarterly report, period 2024-09-30 | 0001437749-24-034916 |
| 2024-11-12 | 21:24 ET | [8-K](/filings/0001437749-24-034565.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034565 |
| 2024-09-20 | 20:12 ET | [8-K](/filings/0001437749-24-029747.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-029747 |
| 2024-08-14 | 21:36 ET | [10-Q](/filings/0001437749-24-026474.md) | Quarterly report, period 2024-06-30 | 0001437749-24-026474 |
| 2024-08-13 | 20:17 ET | [8-K](/filings/0001437749-24-026397.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-026397 |
| 2024-08-09 | 21:06 ET | [8-K](/filings/0001193125-24-197943.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-197943 |
| 2024-08-08 | 20:09 ET | [8-K](/filings/0001193125-24-196961.md) | 2.02 Results of operations | 0001193125-24-196961 |
| 2024-08-05 | 23:06 ET | [8-K](/filings/0001437749-24-024543.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-024543 |
| 2024-07-12 | 20:37 ET | [8-K](/filings/0001437749-24-022668.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001437749-24-022668 |
| 2024-07-09 | 13:23 ET | [8-K](/filings/0001437749-24-022362.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-022362 |
| 2024-06-03 | 21:06 ET | [8-K](/filings/0001437749-24-019074.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-019074 |
| 2024-05-13 | 20:47 ET | [8-K](/filings/0001437749-24-016275.md) | 5.07 Shareholder vote results | 0001437749-24-016275 |
| 2024-05-09 | 20:34 ET | [10-Q](/filings/0001437749-24-015705.md) | Quarterly report, period 2024-03-31 | 0001437749-24-015705 |
| 2024-05-08 | 11:54 ET | [8-K](/filings/0001437749-24-015210.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-015210 |
| 2024-04-10 | 11:46 ET | [8-K](/filings/0001437749-24-011571.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure | 0001437749-24-011571 |
| 2024-04-03 | 20:15 ET | [DEF 14A](/filings/0001437749-24-010874.md) | Proxy statement, period 2024-05-13 | 0001437749-24-010874 |
| 2024-04-01 | 21:27 ET | [10-K](/filings/0001437749-24-010430.md) | Annual report, period 2023-12-31 | 0001437749-24-010430 |
| 2024-03-28 | 20:35 ET | [8-K](/filings/0001437749-24-009849.md) | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001437749-24-009849 |
| 2024-03-27 | 00:28 ET | [8-K](/filings/0001437749-24-009476.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-009476 |
| 2024-03-05 | 12:34 ET | [8-K](/filings/0001437749-24-006540.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-006540 |
| 2024-03-04 | 13:24 ET | [8-K](/filings/0001437749-24-006365.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-006365 |
| 2024-02-28 | 21:29 ET | [8-K](/filings/0001437749-24-005904.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-24-005904 |
| 2024-02-05 | 22:54 ET | [8-K/A](/filings/0001437749-24-003003.md) | 9.01 Financial statements and exhibits | 0001437749-24-003003 |
| 2024-01-23 | 12:37 ET | [8-K](/filings/0001437749-24-001909.md) | 5.02 Departure or appointment of officers or directors | 0001437749-24-001909 |
| 2024-01-08 | 13:03 ET | [8-K](/filings/0001437749-24-000822.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001437749-24-000822 |

Page 1 of 6. [Older](/companies/zvra/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.